Singular Genomics to Report Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024

Rhea-AI Summary

Singular Genomics Systems, Inc. (Nasdaq: OMIC) will report financial results for Q4 and full year 2023 on March 18, 2024. The company utilizes next-gen sequencing and multiomics tech. Investors can join the conference call for insights.

SAN DIEGO, March 04, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced that it will report financial results for the fourth quarter and full year ended December 31, 2023 after the market close on Monday, March 18, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Investors interested in listening to the conference call may do so by dialing 1-877-545-0523 for domestic callers or 1-973-528-0016 for international callers and using conference ID 476908 approximately five minutes prior to the start time. A live and archived webcast of the event will be available at investor.singulargenomics.com, in the Presentations & Events section.

About Singular Genomics Systems, Inc.
Singular Genomics is a life science technology company that develops next-generation sequencing and multiomics technologies. The commercially available G4 Sequencing Platform is a powerful, highly versatile benchtop genomic sequencer designed to produce fast and accurate results. In addition, the company is currently developing the G4X Spatial Sequencer, which will leverage Singular’s proprietary sequencing technology, applying it as an in situ readout for transcriptomics, proteomics and fluorescent H&E in tissue, with spatial context and on the same platform as the G4. Singular Genomics’ mission is to empower researchers and clinicians to advance science and medicine. Visit www.singulargenomics.com for more information.

Investor Contact
Matt Clawson
949-370-8500
ir@singulargenomics.com

Media Contact
Dan Budwick, 1AB
973-271-6085
dan@1abmedia.com

FAQ

When will Singular Genomics Systems report financial results for Q4 and full year 2023?

Singular Genomics Systems will report financial results for the fourth quarter and full year ended December 31, 2023 on March 18, 2024.

What technologies does Singular Genomics Systems utilize?

Singular Genomics Systems leverages novel next-generation sequencing (NGS) and multiomics technologies.

How can investors listen to the conference call discussing the financial results?

Investors can listen to the conference call by dialing 1-877-545-0523 for domestic callers or 1-973-528-0016 for international callers using conference ID 476908.

Where can a live and archived webcast of the event be accessed?

A live and archived webcast of the event will be available at investor.singulargenomics.com, in the Presentations & Events section.